ALT

Altimmune News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Altimmune Inc ALT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.15 1.62% 9.39 11:18:34
Open Price Low Price High Price Close Price Prev Close
9.20 9.18 9.78 9.24
more quote information »

Recent News

Date Time Source Heading
8/03/20217:00IHNWFeaturedCEO Presenting on the Emerging Growth Conference on August 4.  Register Now
8/03/20217:13IHNWFeaturedManganese X Energy Advances Preliminary Economic Assessment of Battery Hill Manganese Project with Improved Flowsheet Optimisation Demonstrating Significant Cost Savings in the Production of High Grade Battery Material
8/02/202119:01EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
6/30/202105:46TRMNAltimmune Not Immune to Poor Results; Drops AdCOVID Vaccine..
6/29/202116:31EDGARCurrent Report Filing (8-k)
6/29/202116:15SEEKAltimmune to scrap COVID-19 vaccine program after..
6/29/202116:01GLOBEAltimmune Announces Update on AdCOVID™ Phase 1 Clinical..
6/16/202114:09SEEKAltimmune up 19% after positive data on diabetes candidate,..
6/16/202107:19SEEKAltimmune rises 5% on positive ALT-801 data in early-stage..
6/16/202107:16EDGARCurrent Report Filing (8-k)
6/16/202107:00GLOBEAltimmune Announces Positive Interim Data from ALT-801 Phase..
6/02/202119:00EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202107:00GLOBEAltimmune to Present at the 2021 Jefferies Virtual..
5/26/202107:13SEEKAltimmune gains 7% after AdCOVID shows strong immune..
5/26/202107:00GLOBEAltimmune Demonstrates Strong Neutralization of South..
5/17/202111:54SEEKAltimmune Q1 loss soars 282% as expenses rise dramatically;..
5/17/202107:13EDGARQuarterly Report (10-q)
5/17/202107:08EDGARCurrent Report Filing (8-k)
5/17/202107:05SEEKAltimmune EPS beats by $0.28, misses on revenue
5/17/202107:00GLOBEAltimmune Announces First Quarter 2021 Financial Results and..
5/11/202107:00GLOBEAltimmune to Announce First Quarter 2021 Financial Results..
5/10/202109:41SEEKAltimmune reports encouraging AdCOVID data in SARS-CoV-2..
5/10/202107:00GLOBEAltimmune Announces New Preclinical Data for AdCOVID™..
5/04/202119:01EDGARStatement of Changes in Beneficial Ownership (4)
4/29/202107:00GLOBEAltimmune to Present at Upcoming Scientific Conferences
4/01/202115:16SEEKAltimmune highlights safety of anthrax vaccine candidate..
4/01/202107:31EDGARCurrent Report Filing (8-k)
4/01/202107:00GLOBEAltimmune Reports Data from its Phase 1b Clinical Trial of..
3/31/202119:01EDGARStatement of Changes in Beneficial Ownership (4)
3/26/202113:45SEEKAstraZeneca’s foray into COVID-19 nasal spray sparks..
3/22/202107:00GLOBEAltimmune Partners with Summit Biosciences to Produce a..
3/15/202108:33SEEKAltimmune shares rise 11% as COVID-19 vaccine prevents..
3/15/202107:00GLOBEAdCOVID™, Altimmune’s Single Dose, Intranasal COVID-19..
3/14/202105:18TRMNAltimmune Extends Lonza Partnership To Support Production Of..
3/12/202106:44DJNAltimmune Expands Manufacturing Agreement for Covid-19..
3/12/202103:18SEEKAltimmune expands AdCOVID manufacturing pact with Lonza
3/12/202101:00GLOBEAltimmune Expands AdCOVID™ Manufacturing Collaboration with..
3/08/202116:01GLOBEAltimmune to Present at Upcoming Conferences
3/01/202116:09EDGARStatement of Ownership (sc 13g)
3/01/202116:04EDGARStatement of Changes in Beneficial Ownership (4)
2/25/202116:06EDGARCurrent Report Filing (8-k)
2/25/202108:19EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/25/202107:19SEEKAltimmune EPS beats by $0.68, beats on revenue
2/25/202107:12EDGARAnnual Report (10-k)
2/25/202107:10SEEKAltimmune starts enrollment in phase 1 COVID-19 trial of..
2/25/202107:07EDGARCurrent Report Filing (8-k)
2/25/202107:03GLOBEAltimmune Commences Enrollment in Phase 1 Clinical Trial of..
2/25/202107:00GLOBEAltimmune Announces Financial Results for the Year Ended..
2/22/202116:30GLOBEAltimmune To Announce Year End 2020 Financial Results on..
2/17/202111:49SEEKFDA clears IND for Altimmune intranasal COVID-19 vaccine..
2/17/202107:02GLOBEAltimmune Announces FDA Clearance of AdCOVID™ IND..
See more news about this stock »


Your Recent History
NASDAQ
ALT
Altimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.